RTM is, essentially, the use of a medical device (as defined by the Food and Drug Administration) to monitor a patient’s health or response to treatment using non-physiological data. There are 5 new codes for RTM services this year. Effective January 1, 2022, health care providers can use these codes to monitor and review data related to signs, symptoms, and functions of a therapeutic response.